The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.50
Bid: 72.00
Ask: 75.00
Change: 0.50 (0.68%)
Spread: 3.00 (4.167%)
Open: 73.00
High: 73.50
Low: 73.00
Prev. Close: 73.00
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement regarding Satago and Trading Update

20 Jan 2023 07:00

RNS Number : 3311N
TruFin PLC
20 January 2023
 

20 January 2023

 

TruFin plc("TruFin" or the "Company")

 

Statement regarding Satago and Trading Update

 

Statement regarding Satago

 

TruFin is pleased to announce that Satago Financial Solutions Limited ("Satago") has delivered the trial phase of its fully digitised end-to-end invoice finance solution with Lloyds Bank plc (the "Bank"). The Bank is now testing the digitised proposition ahead of customer onboarding. We look forward to updating shareholders on the progress of this partnership in due course.

 

Trading update

 

Revenues for the 12 months ended 31 December 2022 are expected to be no less than £16.0m (FY21: £13.1m), representing year-on-year growth in excess of 22%. This has predominantly been driven by revenue growth of more than 350% at Satago and over 25% growth at Oxygen Finance Group Limited (together with its subsidiaries Oxygen Finance Limited and Oxygen Finance Americas) ("Oxygen").

 

The Adjusted Loss Before Tax is expected to be in line with market expectations at no more than £8.1m (FY21: £8.4m).

 

Oxygen

 

Oxygen continued to make considerable progress during 2022. Revenue is expected to be no less than £5.3m (FY21: £4.1m) and EBITDA is expected to more than double to not less than £1.1m (FY21: £0.5m). Given its robust progress and strong financial outlook, Oxygen made its first dividend payment (of £0.25m) to TruFin in December.

 

Oxygen dominates its niche markets and is becoming increasingly attractive to a growing pool of potential acquirers - as demonstrated by the recent unsolicited indicative offer which the Board of TruFin rejected, as announced on 22 December 2022.

 

Satago

 

Revenues increased more than 350% to no less than £2.1m (FY21: £0.5m). Growth was driven by Satago's successful pivot towards lending as a service ("LaaS") which, combined with its targeted proprietary lending book, make it increasingly attractive to other commercial partners. 

 

Satago's focus is to deliver on significant contracts signed in 2022 and to win new customers from an exciting pipeline of opportunities.

 

Playstack

 

During 2022 Playstack Limited ("Playstack") launched two critically acclaimed games, The Entropy Centre and The Case of the Golden Idol. It also successfully integrated Magic Fuel Inc. ("Magic Fuel") following acquisition of the remote games developer in June and delivered on key contract milestones for their technology platform partner.

 

Revenues in FY22 are expected to be no less than £6.2m (FY21: £7.1m), following the previously announced delay to a key console game title. The rescheduled game launch is not expected to impact the financial support that Playstack requires from TruFin.

 

2023 is expected to be key for Playstack. Several landmark game launches are planned throughout the year and it boasts a growing collection of exciting titles to evaluate, selected by Magnitude, Playstack's proprietary sourcing technology.

 

Vertus

 

Vertus Capital Limited ("Vertus") continues to perform well, with no credit losses incurred to date and an increasing pipeline of opportunities. Vertus recorded its second full year of profitability during FY22, with profit before tax at no less than £0.2m (FY21: £0.01m). Despite two early repayments, its loan book grew by over 38% to £21.4m (FY21: £15.6m). New loan facilities grew very strongly, up 80%. Revenue increased 57% to £2.2m (FY21: £1.4m) and Vertus' unique position in the marketplace ensures it is well-positioned to achieve another full year of profitable growth during 2023.

 

James van den Bergh, Chief Executive Officer, commented:

 

"Despite a tough macroeconomic backdrop, 2022 was another year of significant progress for TruFin. Numerous internal records at Oxygen culminated in their inaugural dividend to TruFin - highlighting their position as a financially independent subsidiary. Satago's two partnerships with FTSE100 companies were particularly pleasing to conclude and with revenue growth of more than 350% the direction of travel is clear. Playstack's acquisition of Magic Fuel and its growing portfolio of opportunities should allow 2023 to be a transition year for Playstack, whilst Vertus achieved their second full year of profitable growth.

 

The Board is confident that there is scope for significant value creation for our shareholders and we look forward to updating them on progress in the coming months."

 

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.

For further information, please contact:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

0203 100 2000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBKLLFXFLBBBK
Date   Source Headline
9th Jun 20207:00 amRNSNotice of Annual General Meeting Posting
1st Jun 20202:52 pmRNS2020 Annual General Meeting and Board Changes
15th May 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
13th May 202011:05 amRNSHolding(s) in Company
13th May 20207:00 amRNSHolding(s) in Company
11th May 202010:43 amRNSHolding(s) in Company
29th Apr 202010:33 amRNSAppointment of a Non-Executive Director
24th Mar 20207:00 amRNSPre-Close Trading Update
20th Mar 20204:00 pmRNSStatement Regarding Satago
21st Feb 20207:00 amRNSVesting of JSOP Founder Awards
24th Dec 20197:00 amRNSResult of Tender Offer
23rd Dec 201910:26 amRNSGeneral Meeting Results
4th Dec 20197:00 amRNSProposed Tender Offer and Trading Update
8th Nov 20197:00 amRNSQ3 Trading Update
26th Sep 20194:33 pmRNSResults of Written Resolutions
13th Sep 20193:55 pmRNSStatement Regarding Closure of Arrowgrass
11th Sep 20194:21 pmRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNS2019 Interim Results and Company Updates
29th Jul 20197:00 amRNSRestructuring and Update
5th Jun 20197:00 amRNSResult of Tender Offer
4th Jun 20191:19 pmRNSResult of AGM
17th May 20197:00 amRNSNotice of Tender Offer and AGM
9th May 20197:00 amRNSDemerger Effective And DFC Holdings Admission
7th May 201911:46 amRNSGeneral Meeting Results & Completion Of Zopa Sale
3rd May 20195:30 pmRNSTruFin
24th Apr 20193:59 pmRNSDirector/PDMR Shareholding
17th Apr 20196:20 pmRNSResult of Placing
17th Apr 20192:44 pmRNSStrategic Update, Demerger of DFC and Zopa Sale
17th Apr 20192:41 pmRNSFinal Results for the year ended 31 December 2018
22nd Feb 201911:17 amRNSVesting of Share Incentive/Options for PDMRs
7th Dec 20184:05 pmRNSProgress Update
4th Dec 20187:00 amRNSZopa Banking Licence
29th Nov 20187:01 amRNSStrategy/Company/Ops Update
29th Nov 20187:00 amRNSChange of Adviser
14th Sep 20189:04 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSHalf-year Report
6th Aug 20186:29 pmRNSAcquisition of Porge Ltd by Oxygen Finance Group
3rd Aug 20187:00 amRNSZopa Fundraising
13th Jul 20185:39 pmRNSDirector/PDMR Shareholding
13th Jul 20185:26 pmRNSDirector/PDMR Shareholding
19th Jun 201812:17 pmRNSResult of AGM
1st Jun 20186:30 pmRNSHolding(s) in Company
1st Jun 20184:00 pmRNSPosting of Annual Report and Notice of AGM
30th May 20187:00 amRNSDirector/PDMR Shareholding
30th May 20187:00 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSFinal Results for the year ended 31 December 2017
23rd Feb 201810:59 amRNSDirector/PDMR Shareholding
21st Feb 20187:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.